AAAAAA

   
Results: 1-7 |
Results: 7
Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists
Authors: Barrow, JC Nantermet, PG Selnick, HG Glass, KL Ngo, PL Young, MB Pellicore, JM Breslin, MJ Hutchinson, JH Freidinger, RM Condra, C Karczewski, J Bednar, RA Gaul, SL Stern, A Gould, R Connolly, TM
Citation: Jc. Barrow et al., Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists, BIOORG MED, 11(20), 2001, pp. 2691-2696
A facile three-step synthesis of 1,2-amino alcohols using the Ellman homochiral tert-butylsulfinamide
Authors: Barrow, JC Ngo, PL Pellicore, JM Selnick, HG Nantermet, PG
Citation: Jc. Barrow et al., A facile three-step synthesis of 1,2-amino alcohols using the Ellman homochiral tert-butylsulfinamide, TETRAHEDR L, 42(11), 2001, pp. 2051-2054
Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha(1a)-receptor antagonists
Authors: Barrow, JC Glass, KL Selnick, HG Freidinger, RM Chang, RSL O'Malley, SS Woyden, C
Citation: Jc. Barrow et al., Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha(1a)-receptor antagonists, BIOORG MED, 10(17), 2000, pp. 1917-1920
Selective alpha(1a) adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones
Authors: Nantermet, PG Barrow, JC Selnick, HG Homnick, CF Freidinger, RM Chang, RSL O'Malley, SS Reiss, DR Broten, TP Ransom, RW Pettibone, DJ Olah, T Forray, C
Citation: Pg. Nantermet et al., Selective alpha(1a) adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones, BIOORG MED, 10(15), 2000, pp. 1625-1628
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia
Authors: Barrow, JC Nantermet, PG Selnick, HG Glass, KL Rittle, KE Gilbert, KF Steele, TG Homnick, CF Freidinger, RM Ransom, RW Kling, P Reiss, D Broten, TP Schorn, TW Chang, RSL O'Malley, SS Olah, TV Ellis, JD Barrish, A Kassahun, K Leppert, P Nagarathnam, D Forray, C
Citation: Jc. Barrow et al., In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia, J MED CHEM, 43(14), 2000, pp. 2703-2718
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase
Authors: Liverton, NJ Butcher, JW Claiborne, CF Claremon, DA Libby, BE Nguyen, KT Pitzenberger, SM Selnick, HG Smith, GR Tebben, A Vacca, JP Varga, SL Agarwal, L Dancheck, K Forsyth, AJ Fletcher, DS Frantz, B Hanlon, WA Harper, CF Hofsess, SJ Kostura, M Lin, J Luell, S O'Neill, EA Orevillo, CJ Pang, M Parsons, J Rolando, A Sahly, Y Visco, DM O'Keefe, SJ
Citation: Nj. Liverton et al., Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase, J MED CHEM, 42(12), 1999, pp. 2180-2190
Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I-Ks, in canine models of malignant ischemic ventricular arrhythmia
Authors: Lynch, JJ Houle, MS Stump, GL Wallace, AA Gilberto, DB Jahansouz, H Smith, GR Tebben, AJ Liverton, NJ Selnick, HG Claremon, DA Billman, GE
Citation: Jj. Lynch et al., Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I-Ks, in canine models of malignant ischemic ventricular arrhythmia, CIRCULATION, 100(18), 1999, pp. 1917-1922
Risultati: 1-7 |